摘要
目的探讨临床药师如何对PD-1致免疫相关性胰腺炎患者实施药学监护。方法以1例非小细胞肺癌患者使用PD-1导致免疫相关性胰腺炎为例,协助治疗团队判定是否为免疫相关性胰腺炎及其严重程度,协助制定以糖皮质激素治疗为主的治疗方案。结果在临床药师与治疗团队的密切配合下,患者获得了较为完善的药物治疗方案与药学监护,使免疫相关性胰腺炎指标趋于正常,临床症状改善。结论临床药师介入免疫相关性胰腺炎的药物治疗,使临床用药更趋合理,有利于提高临床药物治疗水平和疾病治疗的有效率。
OBJECTIVE To explore the pharmaceutical care for PD-1-induced pancreatitis performed by clinical pharmacists. METHODS The pharmacist assisted the treatment team to determine whether it was immune-related pancreatitis caused by sintilimab in a non small cell lung cancer patient and its severity, formulated a treatment plan based on glucocorticoid. RESULTS The patient’s clinical symptoms and immune-related pancreatitis indicators had been improved after the clinical pharmacist and the treatment team formulating a good treatment plan and pharmaceutical care plan. CONCLUSION Clinical pharmacists participate in medical treatment of immune-associated pancreatitis, which can make clinical medication more rational and help to improve the treatment effect.
作者
周花萍
陈永
ZHOU Huaping;CHEN Yong(Guangzhou 8th People’s Hospital,Guangzhou,Guangdong 510030,China;The First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou,Guangdong 510030,China)
出处
《今日药学》
CAS
2021年第5期392-395,共4页
Pharmacy Today
